Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-22

Clinical Trial Update: TaVNS for Delirium [NA]

View source ↗

Summary

A Stony Brook University-sponsored trial is evaluating TaVNS (transcutaneous auricular vagus nerve stimulation) for delirium and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • taVNS (transcutaneous auricular vagus nerve stimulation)

Snippet

Sponsor: Stony Brook University | Conditions: Delirium Treatment, Delirium | NA | Status: RECRUITING